Tactile Systems Technology Inc (NASDAQ:TCMD) COO Robert J. Folkes sold 2,106 shares of the firm’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $45.11, for a total value of $95,001.66. Following the sale, the chief operating officer now directly owns 79,960 shares in the company, valued at approximately $3,606,995.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
NASDAQ:TCMD traded down $0.59 during trading hours on Monday, hitting $42.32. 155,473 shares of the company were exchanged, compared to its average volume of 235,793. The stock has a market capitalization of $815.43 million, a price-to-earnings ratio of 124.47, a price-to-earnings-growth ratio of 3.64 and a beta of 2.06. The company has a current ratio of 5.04, a quick ratio of 4.34 and a debt-to-equity ratio of 0.02. Tactile Systems Technology Inc has a one year low of $37.40 and a one year high of $76.63. The company has a fifty day simple moving average of $49.80 and a 200 day simple moving average of $52.82.
Tactile Systems Technology (NASDAQ:TCMD) last announced its earnings results on Monday, August 5th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.09. The business had revenue of $45.20 million during the quarter, compared to analyst estimates of $42.60 million. Tactile Systems Technology had a return on equity of 9.19% and a net margin of 5.05%. Tactile Systems Technology’s revenue for the quarter was up 32.4% compared to the same quarter last year. During the same period last year, the company earned $0.13 EPS. Equities research analysts predict that Tactile Systems Technology Inc will post 0.6 earnings per share for the current fiscal year.
A number of large investors have recently made changes to their positions in TCMD. Marshall Wace North America L.P. bought a new position in shares of Tactile Systems Technology in the 1st quarter worth about $25,000. TCI Wealth Advisors Inc. raised its position in shares of Tactile Systems Technology by 2,500.0% in the 2nd quarter. TCI Wealth Advisors Inc. now owns 520 shares of the company’s stock worth $30,000 after acquiring an additional 500 shares in the last quarter. First Mercantile Trust Co. raised its position in shares of Tactile Systems Technology by 27.8% in the 2nd quarter. First Mercantile Trust Co. now owns 2,768 shares of the company’s stock worth $158,000 after acquiring an additional 602 shares in the last quarter. Alberta Investment Management Corp bought a new position in shares of Tactile Systems Technology in the 2nd quarter worth about $222,000. Finally, Piedmont Investment Advisors Inc. bought a new position in shares of Tactile Systems Technology in the 1st quarter worth about $225,000. 99.67% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts recently weighed in on the company. Zacks Investment Research downgraded Tactile Systems Technology from a “buy” rating to a “hold” rating in a report on Tuesday, August 20th. BTIG Research raised Tactile Systems Technology from a “neutral” rating to a “buy” rating and set a $62.00 price objective on the stock in a report on Wednesday, August 7th. TheStreet raised Tactile Systems Technology from a “d+” rating to a “c+” rating in a report on Monday, July 29th. ValuEngine raised Tactile Systems Technology from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. Finally, Dougherty & Co began coverage on Tactile Systems Technology in a research report on Thursday, June 13th. They set a “buy” rating and a $80.00 target price for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $73.29.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.
Featured Story: Growth and Income Funds
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.